HMP Global July 21, 2025
Dr Randy Vogenberg explores how employers, providers, and manufacturers must collaborate more effectively to navigate the complex challenges of benefit design, patient access, and financial planning in the face of rapidly evolving and costly therapies like gene and cell treatments.
F. Randy Vogenberg, PhD, FASHP: I’m Randy Vogenberg, and I’m principal for the Institute for Integrated Healthcare. I’m also on the board leadership for the Employer Provider Council, which deals with employer organizations around the country as well as providers and collaborations with manufacturers.
Can you provide a brief overview of this program?
Vogenberg: This is an annual program that we’ve been doing for 15 years. I’m the co-founder and co-leader for the program, which is done with the Midwest...
Today's Sponsors
Today's Sponsor